Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-02-10

Clinical Trial Update: Study to Assess the Real-World Effectiveness of Ubrogepant in Adult Participants When Treating During the Prodrome Phase of Migraine Attacks

View source ↗

Summary

This clinical trial update describes a real-world study evaluating the effectiveness of ubrogepant when used during the prodrome phase of migraine attacks in ad…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Ubrelvy (ubrogepant)

Snippet

Sponsor: AbbVie | Conditions: Migraine | Status: RECRUITING